12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

RG1662: Phase I started

In its 3Q12 earnings, Roche said that it began a Phase I trial to evaluate multiple doses of RG1662 over...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >